Post-marketing safety profile of solriamfetol: A real-world disproportionality analysis using FDA adverse event reporting system (FAERS) database.
OA: gold
publisher-OA-unknown
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-06-16T06:07:01.518242+00:00
- unpaywall
- last seen: 2026-05-21T05:10:58.409756+00:00
License: publisher-OA-unknown
· commercial use NOT OK
· attribution required